Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis.

Takada, Kazuki

Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis. [electronic resource] - Arthritis and rheumatism Jul 2004 - 2202-10 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0004-3591

10.1002/art.20338 doi


Adult
Alleles
Antirheumatic Agents--administration & dosage
Cohort Studies
Cyclophosphamide--administration & dosage
Cytochrome P-450 Enzyme System--genetics
Female
Gene Frequency
Genetic Variation
Genotype
Homozygote
Humans
Kidney Failure, Chronic--etiology
Lupus Nephritis--complications
Male
Middle Aged
Polymorphism, Genetic
Predictive Value of Tests
Primary Ovarian Insufficiency--chemically induced
Pulse Therapy, Drug
Retrospective Studies
Risk Factors
Treatment Outcome